Clinical and biochemical impact of the d3 growth hormone receptor genotype in acromegaly

Journal of Clinical Endocrinology and Metabolism

Volumn 93, Issue 9, 2008, Pages 3411-3415

  Mercado, Moisés ^a,b   González, Baldomero ^a   Sandoval, Carolina ^a   Esquenazi, Yoshua ^a   Mier, Fernando ^a   Vargas, Guadalupe ^a   De Los Monteros, Ana Laura Espinosa ^a   Sosa, Ernesto ^a  

^a HOSPITAL DE ESPECIALIDADES   (Mexico)

^b NONE   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; SOMATOSTATIN DERIVATIVE;

ACROMEGALY; ADULT; AGED; ARTHRALGIA; ARTICLE; BIOCHEMISTRY; BLOOD DONOR; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; EXON; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GENETIC EPIDEMIOLOGY; GENOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HORMONE SENSITIVITY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MULTIPLE REGRESSION; NEUROPATHY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDY; SLEEP APNEA SYNDROME; TERTIARY HEALTH CARE; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 51649113457     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2008-0391     Document Type: Article

References (25)

1. Leung DW, Spencer SA, Cachianes G, Hammonds RG, Collins C, Henzel WJ, Barnard R, Waters MJ, Wood WI 1987 Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 330:537-543
2. Godowski PJ, Leung DW, Meacham LR, Galgani JP, Hellmiss R, Keret R, Rotwein PS, Parks JS, Laron Z, Wood WI 1989 Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism. Proc Natl Acad Sci USA 86:8083-8087
3. Urbanek M, MacLeod JN, Cooke NE, Liebhaber SA 1992 Expression of a human growth hormone (hGH) receptor isoform is predicted by tissue-specific alternative splicing of exon 3 of the hGH receptor. Mol Endocrinol 6:279-287
4. Mercado M, Dávila N, McLeod JF, Baumann G 1994 Distribution of growth hormone receptor messenger ribonucleic acid containing and lacking exon 3 in human tissues. J Clin Endocrinol Metab 78:731-735
5. Pantel J, Machinis K, Sobrier ML, Duquesnoy P, Goossens M, Amselem S 2000 Species-specific alternative splice mimicry at the growth hormone receptor locus revealed by the lineage of retroelements during primate evolution. J Biol Chem 275:18664-18669
6. Dos Santos C, Essioux L, Teinturier C, Tauber M, Goffin V, Bougneres P 2004 A common polymorphism of the growth hormone receptor is associated with increased responsiveness to growth hormone. Nat Genet 36:720-724
7. Audi L, Esteban C, Carrascosa A, Espadero R, Pérez-Arroyo A, Arjona R, Clemente M, Wollman H, Fryklund L, Parodi LA 2006 Exon 3-deleted/fulllength growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in adult control population (n = 289) show increase fl/fl in short SGA. J Clin Endocrinol Metab 91:5038-5043
8. Sobrier ML, Duquesnoy P, Duriez B, Amselem S, Goossens M 1993 Expression and binding properties of two isoforms of the growth hormone receptor. FEBS Lett 319:16-20
9. Urbanek M, Russell JE, Cooke NE, Liebhaber SA 1993 Functional characterization of the alternatively spliced, placental human growth hormone receptor. J Biol Chem 268:19025-19032
10. Binder G, Baur F, Schweizer R, Ranke MB 2006 The d3-growth hormone (GH) receptor polymorphism is associated with increased responsiveness to GH in Turner syndrome and short small-for-gestational-age children. J Clin Endocrinol Metab 91:659-664
11. Jorge AA, Marchisotti FG, Montenegro LR, Carvalho LR, Mendonca BB, Arnhold IJ 2006 Growth hormone (GH) pharmacokinetics: influence of GH receptor exon 3 retention or deletion on first-year growth response and final height in patients with severe GH deficiency. J Clin Endocrinol Metab 91:1076-1080
12. Carrascosa A, Esteban C, Espadero R, Fernández-Cancio M, Andaluz P, Clemente M, Audí L, Wollman H, Fryklund L, Parodi L, Spanish SGA Study Group 2006 The d3/fl-growth hormone(GH) receptor polymorphism does not influence the effect of GH treatment (66 μg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients. J Clin Endocrinol Metab 91:3281-3286
13. Blum WF, Machinas K, Shavrikova EP, Keller A, Stobbe H, Pfaeffle RW, Amselem S 2006 The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon3-minus isoform of the GH receptor. J Clin Endocrinol Metab 91:4171-4174
14. Carrascosa A, Audi L, Esteban C, Fernández-Cancio M, Andaluz P, Gussinye M, Clemente M, Yeste D, Albisu MA 2008 Growth hormone (GH) dose, but not exon 3-deleted/full-length GH receptor polymorphism genotypes, influences growth response to two-year GH therapy in short small-for-gestational age children. J Clin Endocrinol Metab 93:147-153
15. Raz B, Janner M, Petkovik V, Lochmatter D, EblA, Dattani MT, Hindmarsh PC, FDlack CE, Mullis PE 2008 Influence of growth hormone receptor d3 and full-length isoforms on growth hormone response and final height in patients with severe growth hormone deficiency. J Clin Endocrinol Metab 93:974-980
16. Ben-Shlomo A, Melmed S 2008 Acromegaly. Endocrinol Metab Clin North Am 37:101-122
17. Mercado M, Espinosa de los Monteros AL, Sosa E, Cheng S, Mendoza V, Hernández I, Sandoval C, Guinto G, Molina M 2004 Clinical-biochemical correlations in acromegaly at diagnosis and the real prevalence of biochemically discordant disease. Horm Res 62:293-299
18. Alberti KG, Zimmet PZ 1998 Definition, diagnosis and classification of diabetes mellitus and its complications. Part I. Diagnosis and classification of diabetes mellitus, provisional report of a WHO consult. Diabet Med 15:539-553
19. de Vos AM, Ulñtsch M, Kossiakoff AA 1992 Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312
20. Bass SH, Mulkerrin MG, Wells JA 1991 A systematic mutational analysis of the hormone-binding determinants in the human growth hormone receptor. Proc Natl Acad Sci USA 88:4498-4502
21. Horan M, Newsway V, Yasmin, Lewis MD, Easter TE, Rees DA, Mahto A, Millar DS, Procter AM, Scanlon MF, Wilkinson IB, Hall IP, Wheatley A, Blakey J, Bath PM, Cockcroft JR, Krawczak M, Cooper DN 2006 Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke. Hum Gen 119:527-540
22. Schmid C, Krayenbuehl PA, Bernays RL, Zwimpfer C, Maly FE, Wiesli P 2007 Growth hormone (GH) receptor isoform in acromegaly: lower concentrations of GH but not insulin-like growth factor-1 in patients with a genomic deletion of exon 3 in the GH receptor gene. Clin Chem 53:1484-1488
23. Jaffe CA, Pan W, Brown MB, DeMott-Frieberg R, Barkan AL 2001 Regulation of GH secretion in acromegaly: reproducibility of daily GH profiles and attenuated negative feedback by IGF-I. J Clin Endocrinol Metab 86:4364-4370
24. Espinosa-de-los-Monteros AL, Sosa E, Cheng S, Ochoa R, Sandoval C, Guinto G, Mendoza V, Hernández I, Molina M, Mercado M 2006 Biochemical evaluation of disease activity after pituitary surgery in acromegaly: a critical analysis of patients who spontaneously change disease status. Clin Endocrinol 64:245-249
25. Colao A, Arnaldi G, Beck-Peccoz P, Cannavò S, Cozzi R, degli Uberti E, De Marinis L, De Menis E, Ferone D, Gasco V, Giustina A, Grottoli S, Lombardi G, Maffei P, Martino E, Minuto F, Pivonello R, Ghigo E 2007 Pegvisomant in acromegaly: why, when, how. J Endocrinol Invest 30:693-699